Literature DB >> 14690341

Atopic dermatitis is increased following vaccination for measles, mumps and rubella or measles infection.

Anne Braae Olesen1, Svend Juul, Kristian Thestrup-Pedersen.   

Abstract

The prevalence of atopic dermatitis increased markedly in the period 1960s to the 1990s. Earlier findings indicate that infections acquired in early life enhance or suppress the expression of atopic disease as a result of a change in immune reactivity. Our objectives were to examine the association between measles, mumps and rubella vaccination, measles infection and the risk of atopic dermatitis. A random sample of 9,744 children were followed up from birth to 3-15 years. Their parents responded to a questionnaire including highly structured questions on atopic dermatitis, measles, mumps and rubella vaccination and measles infection. Information on parental educational level was obtained from Statistics Denmark. The cumulative incidence of atopic dermatitis at age 14 was 19.7%. The confounder adjusted incidence ratio of atopic dermatitis among measles, mumps and rubella vaccinated children versus children not subjected to measles, mumps and rubella vaccination and measles infection was 1.86 (95% CI 1.25-2.79); the incidence ratio for measles-infected children was similar. The incidence of atopic dermatitis increased after measles, mumps and rubella vaccination and measles infection, which is surprising in view of the hygiene hypothesis. We suggest further study of the possible short-term and long-term effects of virus and bacteria on the immune responses and expression of atopic disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14690341     DOI: 10.1080/00015550310014997

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  5 in total

1.  Asthma and allergy in children with and without prior measles, mumps, and rubella vaccination.

Authors:  Clara Amalie Gade Timmermann; Christa Elyse Osuna; Ulrike Steuerwald; Pál Weihe; Lars K Poulsen; Philippe Grandjean
Journal:  Pediatr Allergy Immunol       Date:  2015-05-11       Impact factor: 6.377

Review 2.  Role in Allergic Diseases of Immunological Cross-Reactivity between Allergens and Homologues of Parasite Proteins.

Authors:  Helton da Costa Santiago; Thomas B Nutman
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

Review 3.  Role of primary and secondary prevention in atopic dermatitis.

Authors:  Magdalena Oszukowska; Iwonna Michalak; Katarzyna Gutfreund; Wojciech Bienias; Marta Matych; Anna Szewczyk; Andrzej Kaszuba
Journal:  Postepy Dermatol Alergol       Date:  2015-12-11       Impact factor: 1.837

4.  Association of the incidence of atopic dermatitis until 3 years old with climate conditions in the first 6 months of life: Japan Environment and Children's Study (JECS).

Authors:  Hiroshi Yokomichi; Mie Mochizuki; Ryoji Shinohara; Megumi Kushima; Sayaka Horiuchi; Reiji Kojima; Tadao Ooka; Yuka Akiyama; Kunio Miyake; Sanae Otawa; Zentaro Yamagata
Journal:  PLoS One       Date:  2022-05-06       Impact factor: 3.240

5.  Three cases of vesiculobullous non-IgE-mediated cutaneous reactions to tozinameran (Pfizer-BioNTech COVID-19 vaccine).

Authors:  L Juay; N S Chandran
Journal:  J Eur Acad Dermatol Venereol       Date:  2021-08-16       Impact factor: 9.228

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.